PET in the Management of Hematologic Malignancies, An Issue of PET Clinics, 1st Edition
Authors :
Abass Alavi & Gary A. Ulaner & Jakub Svoboda & Lale Kostakoglu
Date of Publication: 05/2019
This issue of PET Clinics focuses on PET in the Management of Hematologic Malignancies and is edited by Drs. Abass Alavi (the Consulting Editor of PET Clinics), Gary Ulaner, Jakub Svoboda, and Lale Kostakoglu. Articles will include: PET-CR as a surro ...view more
This issue of PET Clinics focuses on PET in the Management of Hematologic Malignancies and is edited by Drs. Abass Alavi (the Consulting Editor of PET Clinics), Gary Ulaner, Jakub Svoboda, and Lale Kostakoglu. Articles will include: PET-CR as a surrogate to replace PFS in assessment of efficacy of DLBCL treatments; PET-Derived Quantitative Metrics for Response and Prognosis; Evolving Role of PET Based Novel Quantitative Techniques in the Management of Hematological Malignancies; Critical Role of FDG/NaF imaging in Assessment of Skeletal Involvement in Patients with Multiple Myeloma; Response adapted treatment strategies in Hodgkin lymphoma using PET scans; FDG PET/CT as a staging tool in multiple myeloma; FDG PET/CT as a predictor of prognosis in multiple myeloma; PET/CT as a response evaluation tool in multiple myeloma; PET imaging in CLL and Richter’s transformation; Current Overview and Future Directions of PET for Hematologic Malignancies; and more!
This issue of PET Clinics focuses on PET in the Management of Hematologic Malignancies and is edited by Drs. Abass Alavi (the Consulting Editor of PET Clinics), Gary Ulaner, Jakub Svoboda, and Lale Kostakoglu. Articles will include: PET-CR as a surrogate to replace PFS in assessment of efficacy of DLBCL treatments; PET-Derived Quantitative Metrics for Response and Prognosis; Evolving Role of PET Based Novel Quantitative Techniques in the Management of Hematological Malignancies; Critical Role of FDG/NaF imaging in Assessment of Skeletal Involvement in Patients with Multiple Myeloma; Response adapted treatment strategies in Hodgkin lymphoma using PET scans; FDG PET/CT as a staging tool in multiple myeloma; FDG PET/CT as a predictor of prognosis in multiple myeloma; PET/CT as a response evaluation tool in multiple myeloma; PET imaging in CLL and Richter’s transformation; Current Overview and Future Directions of PET for Hematologic Malignancies; and more!
Author Information
Edited by Abass Alavi, MD; Gary A. Ulaner, MD, PhD, FACNM, Associate Attending Radiologist, Memorial Sloan Kettering Cancer Center, New York, New York; Jakub Svoboda and Lale Kostakoglu
Bring it with you - The Bookshelf app allows you to access books on your laptop, tablet or mobile, so your ebooks go where ever you are - online or offline.
Take notes - Highlight, bookmark and take notes and highlights automatically stay in sync no matter where you make them.
Listen to eBooks - When you need to go screenless, the Text-to-speech tool will read your book aloud.
Powerful search - The searching capabilities allow you to search keywords through all your eBooks, the entire Bookshelf Library and well as on Wikipedia.
Ecological - Manage your environmental impact with paperless books.
How to read your VitalSource eBooks
Purchase your VitalSource eBook on the Elsevier Health site
https://www.uk.elsevierhealth.com/pet-in-the-management-of-hematologic-malignancies-an-issue-of-pet-clinics-9780323678780.html82472PET in the Management of Hematologic Malignancies, An Issue of PET Clinicshttps://www.uk.elsevierhealth.com/media/catalog/product/9/7/9780323678780_5.jpg44.2458.99GBPInStock/Medicine and Surgery/Radiology/Books/Clinics Review Articles100295255039561283917453100005145120This issue of PET Clinics focuses on PET in the Management of Hematologic Malignancies and is edited by Drs. Abass Alavi (the Consulting Editor of PET Clinics), Gary Ulaner, Jakub Svoboda, and Lale Kostakoglu. Articles will include: PET-CR as a surrogate to replace PFS in assessment of efficacy of DLBCL treatments; PET-Derived Quantitative Metrics for Response and Prognosis; Evolving Role of PET Based Novel Quantitative Techniques in the Management of Hematological Malignancies; Critical Role of FDG/NaF imaging in Assessment of Skeletal Involvement in Patients with Multiple Myeloma; Response adapted treatment strategies in Hodgkin lymphoma using PET scans; FDG PET/CT as a staging tool in multiple myeloma; FDG PET/CT as a predictor of prognosis in multiple myeloma; PET/CT as a response evaluation tool in multiple myeloma; PET imaging in CLL and Richter’s transformation; Current Overview and Future Directions of PET for Hematologic Malignancies; and more! This issue of PET Clinics focuses on PET in the Management of Hematologic Malignancies and is edited by Drs. Abass Alavi (the Consulting Editor of PET Clinics), Gary Ulaner, Jakub Svoboda, and Lale Kostakoglu. Articles will include: PET-CR as a surrogate to replace PFS in assessment of efficacy of DLBCL treatments; PET-Derived Quantitative Metrics for Response and Prognosis; Evolving Role of PET Based Novel Quantitative Techniques in the Management of Hematological Malignancies; Critical Role of FDG/NaF imaging in Assessment of Skeletal Involvement in Patients with Multiple Myeloma; Response adapted treatment strategies in Hodgkin lymphoma using PET scans; FDG PET/CT as a staging tool in multiple myeloma; FDG PET/CT as a predictor of prognosis in multiple myeloma; PET/CT as a response evaluation tool in multiple myeloma; PET imaging in CLL and Richter’s transformation; Current Overview and Future Directions of PET for Hematologic Malignancies; and more!00add-to-cart97803236787802019ProfessionalEdited by Abass Alavi, MD, Gary A. Ulaner, MD, PhD, FACNM, Jakub Svoboda and Lale Kostakoglu20191Book178w x 254h (7.00" x 10.00")Elsevier031 May 2019PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 10 DAYSEdited by <STRONG>Abass Alavi</STRONG>, MD; <STRONG>Gary A. Ulaner</STRONG>, MD, PhD, FACNM, Associate Attending Radiologist, Memorial Sloan Kettering Cancer Center, New York, New York; <STRONG>Jakub Svoboda</STRONG> and <STRONG>Lale Kostakoglu</STRONG>ClinicsThe Clinics: RadiologyNoNoNoNoPlease SelectPlease SelectPlease Select